Surgical Glue Market Research, 2031
The global surgical glue market was valued at $2.3 billion in 2021 and is projected to reach $4.6 billion by 2031, growing at a CAGR of 7% from 2022 to 2031. The number of topical adhesives, surgical sealants, and hemostats approved for use in the surgical setting is ever-expanding although no single sealant product fills all medical and surgical needs to replace sutures. As more surgical procedures are performed through laparoscopic and robotic approaches, surgical glues are becoming more important, and various research activities have focused on solving the limitations of conventional wound treatments.
The surgical glue is used as a barrier to leaks of fluids, such as blood, urine, or air. For instance, the surgical glue may be used to patch and cover a puncture in the lung. Moreover, the surgical glue may be applied to tissue wounds as hemostatic agents to control bleeding. The recent developments of synthetic glues for internal applications have focused on other polymer materials such as poly(ethylene glycol) (PEG), polyurethanes, and polyesters. These polymer-based glues provide attractive features based on their biocompatibility, degradability, and tunable mechanical properties. A common disadvantage of many of these polymer-based glues is the significant post-polymerization swelling which can potentially cause compression on surrounding tissues or nerves.
The Surgical Glue Market Growth is driven by an increase in the geriatric population, an increase in the number of surgical procedures performed, and an increase in the incidence of wounds and injuries. Furthermore, an increase in the number of road accidents, an increase in awareness regarding surgical glue, and an increase in the prevalence of chronic diseases are considerably contributing toward growth of Surgical Glue Market Size. However, the high cost of surgical glue and availability of alternate products, and in popularity of minimally invasive surgeries are negatively impacting the market growth. Conversely, the high growth potential in emerging countries offers lucrative opportunities for the growth of the Surgical Glue Industry.
The overall impact of COVID-19 on the surgical glue market is negative, owing to the decline observed in the number of surgical procedures performed during the pandemic. A large number of clinics and hospitals across the globe were restructured to increase the hospital capacity for patients diagnosed with COVID-19. The nonessential surgical procedures took a potential backlog due to rapidly rising cases of coronavirus and only elective emergency surgeries were performed. For instance, according to a study published by BioMed Central Ltd, a decrease of 14.8% was observed for elective procedures performed in Germany and around a 6.0% decrease for emergency procedures.
Furthermore, the lockdown led to the disruption of the manufacturing and supply chain of medical devices. However, currently, as the COVID-19 vaccination is increasing globally, the majority of hospitals have resumed surgical procedures and a backlog of postponed surgeries is being cleared. Thus, an increase in the demand for surgical glue is expected for these rescheduled surgeries for orthopedic disease, CVD, ophthalmic disease, and others. Thus, such trends are expected to bring stabilization in the market, and subsequently witness a pre-pandemic growth rate during the forecast period.
The global surgical glue market is segmented based on product, application, end-user, and region. Based on product, the market is classified into natural and synthetic & semi-synthetic. Based on application, the market is classified into central nervous system surgeries, general surgeries, cardiovascular surgeries, orthopedic surgeries, cosmetic surgeries, ophthalmic surgeries, urological surgeries, pulmonary surgeries, and others. Based on end-user, the market is classified into hospitals, ambulatory surgery centers, and others. Region-wise, the market is studied across North America (U.S., Canada, and Mexico), Europe (Germany, France, the UK, Italy, Spain, and the Rest of Europe), Asia-Pacific (China, Japan, Australia, India, South Korea, and Rest of Asia-Pacific), and LAMEA (Brazil, South Africa, Saudi Arabia, and Rest of LAMEA).
The surgical glue market is segmented into End-user, Product, and Application.
By product, the synthetic and semi synthetic segment is anticipated to grow with the largest share during the forecast period. This is attributed to the increase in the use of surgical glue based on synthetic and semi-synthetic components in the healthcare institutions like hospitals. Recent advances in surgical glue products have contributed to improving the preference for glue, thus driving the market growth. On the other side, the natural segment is projected to exhibit the fastest market growth during the Surgical Glue Market Forecast period due to the increased demand for surgical glue in ambulatory surgical centers and the increase in the prevalence of chronic diseases.
By application, the cardiovascular surgeries segment acquired the major Surgical Glue Market Size in 2021 and is anticipated to continue this trend during the forecast period, due to an increase in the incidences of woundsportsort injuries and an increase in the geriatric population as they are more prone to chronic diseases. In addition, the central nervous system surgeries segment is expected to exhibit the fastest market growth during the forecast period due to the higher incidence of wounds from road accidents, burns, and other injury conditions.
By end user, the hospitals segment acquired the largest Surgical Glue Market Share in 2021 and is anticipated to continue this trend during the forecast period. This is attributed to the increase in the number of hospitals globally and the rise in the number of hospital visits for the surgeries to be performed. On the other side, the other segment is projected to exhibit the fastest market growth during the forecast period, owing to an increase in preference of the healthcare professionals for using surgical glue in hospitals for patients in wound care management.
Region-wise, North America accounted for the largest Surgical Glue Market Share of revenue in 2021 and is anticipated to maintain its dominance from 2022 to 2031, owing to the presence of a large patient population, strong presence of key players, ease of product availability, well-developed healthcare infrastructure, the higher number of research, development, & innovation activities in Surgical Glue Industry and higher adoption of advanced technologies. Moreover, Asia-Pacific is also expected to grow at the highest CAGR, owing to an increase in the number of accidents on regular basis and a rise in awareness related to surgical glue for medical and surgical use.
The major companies profiled in the report include Artivion, Inc., B. Braun Melsungen AG, Baxter International Inc., Becton, Dickinson and Company, Cardinal Health, Integra Lifesciences Corporation, Johnson & Johnson, Medtronic plc, Ocular Therapeutix Inc., OptMed, Inc.
Key Benefits For Stakeholders
- This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the surgical glue market analysis from 2021 to 2031 to identify the prevailing Surgical Glue Market Opportunity.
- The market research is offered along with information related to key drivers, restraints, and opportunities.
- Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
- In-depth analysis of the surgical glue market segmentation assists to determine the prevailing market opportunities.
- Major countries in each region are mapped according to their revenue contribution to the global market.
- Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
- The report includes the analysis of the regional as well as global surgical glue market trends, key players, market segments, application areas, and market growth strategies.
Surgical Glue Market Report Highlights
Aspects | Details |
Market Size By 2031 | USD 4.6 billion |
Growth Rate | CAGR of 7% |
Forecast period | 2021 - 2031 |
Report Pages | 290 |
By End user |
|
By Product |
|
By Application |
|
By Region |
|
Key Market Players | Ocular Therapeutix Inc., Vivostat, B. Braun Melsungen AG, CryoLife Inc., Sealantis Ltd., Baxter International Inc., Cohera Medical, Inc., Sanofi, CSL Limited, Johnson & Johnson |
Analyst Review
This section provides various opinions of top-level CXOs in the surgical glue industry. In accordance with several interviews conducted, the utilization of surgical glue is expected to witness a significant rise owing to the increase in incidences of road accidents and the increased prevalence of chronic diseases in both developed and developing economies. Furthermore, the global surgical glue market growth is propelled by a surge in the number of surgeries performed, an increase in collaboration between market players for the development of novel products, and a rise in awareness associated with surgical glue usage.
North America accounted for the highest market share in 2021, owing to the availability of advanced wound care products, surgical glue usage awareness, and heavy expenditure by the government on healthcare infrastructure, followed by Europe and Asia-Pacific. Asia-Pacific is expected to exhibit the fastest market growth due to an increase in the demand for surgical glue for wound closure.
The total market value of the Surgical Glue market is $2340.71 million in 2021.
The forecast period in the report is from 2022 to 2031
North America is the largest regional market for Surgical Glue.
The market value of the Surgical Glue market in 2022 was $2502.22 million.
The top companies that hold the market share in Surgical Glue market are Artivion, Inc., B. Braun Melsungen AG, Baxter International Inc., Becton, Dickinson and Company, Cardinal Health, Integra Lifesciences Corporation, Johnson & Johnson, Medtronic plc, Ocular Therapeutix Inc., and OptMed, Inc.
The base year for the report is 2021.
Yes, Surgical Glue companies are profiled in the report
The key trends in the Surgical Glue market are by an increase in the number of hospitals, advancements in Surgical Glue, and R&D in Surgical Glue treatment.
Loading Table Of Content...